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Objective: The main objectives of this study were to assess the clonal relatedness of Acinetobacter
baumannii carbapenem-resistant isolates recovered from the Iberian Peninsula and to investigate the
production of carbapenemases.
Methods: One hundred and sixty-two imipenem-resistant A. baumannii isolates were collected from
1998 to 2003 in three Portuguese university hospitals. An imipenem-resistant isolate (988FFP strain)
recovered in 1995 from a smaller hospital unit, was also included, as well as an OXA-40-producing
A. baumannii Spanish strain (SM28). Susceptibility tests were carried out by disc diffusion and Etest
methods. DNA fingerprints were obtained by PFGE of Apa I-digested chromosomal DNA. Carbapene-
mase activity was determined by a bioassay and spectrophotometry. The detection of the blaOXA-40
gene was conducted through PCR analysis, cloning and nucleotide sequencing.
Results: All the isolates presented a similar multi-resistance pattern, including imipenem (MIC
>32 mg/L). The Iberian isolates showed an identical PFGE pattern with minor band variations, including
isolate 988FFP collected in 1995. PCR results revealed a blaOXA-type gene in 65 isolates and nucleotide
sequence analysis revealed the presence of the blaOXA-40 gene in seven representative Portuguese iso-
lates from the various geographically dispersed hospitals.
Conclusions: Our results indicate that a multi-resistant epidemic clone of A. baumannii, carrying
blaOXA-40, is disseminated in the Iberian Peninsula, persisting in Portugal since 1995.
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Introduction
Oxacillinases (Ambler class D) with carbapenemase activity,
namely OXA-23, OXA-24, OXA-25, OXA-26, OXA-27 and
OXA-40, have been found mainly in Acinetobacter bau-
mannii isolates from the UK, Spain, Belgium and Singapore.1 – 4
A. baumannii is recognized as an important cause of nosocomial
infections mainly observed in intensive care units. Numerous
outbreaks of Acinetobacter spp. infections have been reported,
often associated with the spread of multi-resistant strains.5,6
Some outbreaks due to imipenem-resistant A. baumannii iso-
lates occurred between 1998 and 2003 in various Portuguese
hospitals located in distinct cities. These isolates were resistant
to most of the alternative antimicrobials. Clonal outbreaks of
infection caused by carbapenem-resistant strains of A. baumannii
have also been reported in Spain.4 – 6 The purposes of this study
were to assess the clonal relatedness of A. baumannii imipenem-
resistant isolates collected from Iberian Peninsula hospitals and
to investigate the production of carbapenemases.
Materials and methods
Bacterial isolates
One hundred and sixty-two multi-resistant A. baumannii isolates
were collected between 1998 and 2003, from different patients
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hospitalized at intensive care units, surgery and medicine wards in
three university teaching hospitals each with more than 600 beds.
One hundred and eight isolates were recovered between October
1998 and September 2000 from Hospital de Santa Maria in Lisboa
(HSM). During the period of January 1999 to October 2000, 23 iso-
lates were collected in Hospitais da Universidade de Coimbra
(HUC) located in the centre of Portugal. The remaining 31 isolates
were collected in Hospital Santo Anto´nio in Porto (HSA), located in
the north, during 2001–2003. A representative strain of the Spanish
isolates from Hospital Santa Marina de Bilbao (SM), the SM28 iso-
late,4 was included in this study, as well as a strain from the
laboratory bacterial collection of Faculdade de Farma´cia da Uni-
versidade of Porto, A. baumannii 988FFP, isolated in 1995 from
an inpatient of Hospital Padre Ame´rico (HPAP), a small hospital
unit located near Porto. This strain presented an antimicrobial
profile identical to the isolates recovered recently.
Bacterial identification and susceptibility tests
All isolates were identified by the API 20NE system (bioMe´rieux,
Marcy l’E´toile, France) and the basic properties of the genus
Acinetobacter. Genospecies identification was carried out by ampli-
fied ribosomal DNA restriction analysis (ARDRA).7
Susceptibility testing was carried out by the disc diffusion
method, according to NCCLS guidelines, using amoxicillin,
co-amoxiclav, ticarcillin, ticarcillin/clavulanic acid, piperacillin–
tazobactam, cefoxitin, cefuroxime, cefotaxime, ceftazidime, ceft-
riaxone, cefpirome, cefepime, aztreonam, imipenem, amikacin,
gentamicin, netilmicin, tobramycin, nalidixic acid, norfloxacin,
ciprofloxacin and polymyxin B discs (Oxoid). MICs of b-lactam
antibiotics were determined by the Etest method (AB Biodisk,
Solna, Sweden), according to the manufacturer’s instructions. The
following b-lactam antibiotics were used: amoxicillin, amoxicillin/-
clavulanic acid (2:1), piperacillin, piperacillin/tazobactam (4 mg/L),
ticarcillin, ticarcillin/clavulanic acid (2 mg/L), ampicillin/sulbactam
(2:1), cefoxitin, ceftriaxone, ceftazidime, cefepime, cefpirome,
aztreonam and imipenem. Resistance was defined according to the
NCCLS guidelines.
Pulsed-field gel electrophoresis
Genomic DNA patterns were analysed by pulsed-field gel electro-
phoresis (PFGE). Chromosomal DNA was digested with ApaI (New
England Biolabs, Izasa, Portugal). The restriction fragments were
separated by electrophoresis in a 1% agarose gel in 0.5TBE buf-
fer, pH 8.0, at 200 V and 158C for 24 h, with pulse time ramp from
5 to 15 s, with a CHEF DRII (Bio-Rad).
Determination of carbapenemase activity
Detection of carbapenemase activity was carried out in crude
extracts by a microbiological assay using imipenem discs (10mg)
impregnated with enzymic extracts and EDTA solution. Inactivation
of imipenem was shown by growth of the Escherichia coli ATCC
25922 strain within the expected inhibition zone. Specific
b-lactamase activity was evaluated in extracts by spectrophotometry
in the presence of zinc or EDTA solutions, as described elsewhere,8
using 65FFC strain (IMP-5 producer) and ATCC 19606 A. bau-
mannii as controls.
PCR amplification, cloning and sequencing of blaOXA gene
The presence of blaOXA genes was determined using the blaOXA-24
primers.5 The amplification reaction conditions were: an initial
denaturation step of 3 min/948C, followed by 30 cycles of dena-
turation 1 min/948C, annealing 1 min/508C and elongation
2 min/728C, with a final extension of 8 min/728C. PCR products
were cloned into the pPCR-Script Cam SK(+) vector according
to the manufacturer’s instructions for the PCR-Script Cam Clon-
ing Kit (Stratagene, Cambridge, UK). E. coli XL10-Gold trans-
formants were selected with chloramphenicol (30 mg/L).
Nucleotide sequences were determined and compared with pub-
lished sequences using CLUSTAL W software.
Results
Bacterial identification and susceptibility tests
The isolates were classified in the complex Acinetobacter cal-
coaceticus–A. baumannii and representative isolates from each
hospital identified by ARDRA as Acinetobacter genospecies 2,
known as A. baumannii. All the isolates showed an identical
b-lactam resistance profile, including resistance to amoxicillin
and its association with clavulanic acid, ureidopenicillins and
their associations, cefoxitin, ceftriaxone, ceftazidime, cefepime,
cefpirome, aztreonam (MICs between 128 and >256 mg/L),
ampicillin/sulbactam (MIC of 64 mg/L) and high resistance to
imipenem (MIC >32 mg/L). Isolates were resistant to ciprofloxa-
cin whereas the susceptibility profile to aminoglycosides was
variable.
DNA fingerprinting
DNA profiles obtained by PFGE of representative isolates from
different Portuguese hospitals, recovered at different times, dif-
fered by only one or two bands (Figure 1), and are closely
related, according to the criteria of Tenover et al.9 Moreover,
the SM28 Spanish strain showed the same overall pattern of
Portuguese isolates.
Carbapenemase activity
The results of the microbiological assay carried out for 54 iso-
lates suggested the production of a carbapenemase not inhibited
by EDTA, except in two HUC isolates (141FFC and 150FFC)
and in one HSA isolate that apparently did not hydrolyse imipe-
nem. The specific b-lactamase activity was determined in strain
988FFP and in 141FFC and 150FFC extracts, for confirmation.
The 988FFP extract hydrolysed imipenem (5.11 nmol/min per
mg of protein) and similar values were obtained when the carba-
penemase activity was evaluated in the presence of zinc and
EDTA (5.07 and 5.13 nmol/min per mg of protein, respectively),
suggesting the production of a serine-b-lactamase with carbape-
nemase activity. The specific activity values of 141FFC and
150FFC extracts (0.12 and 0.41 nmol/min per mg of protein)
were similar to the b-lactamase activity obtained with the
imipenem-susceptible A. baumannii ATCC 19606.
Nucleotide sequence of blaOXA gene
PCR with OXA-24 primers amplified an  980 bp fragment in 65
isolates tested. Seven isolates, two from each hospital (including
141FFC isolate) and the 988FFP strain were selected for cloning.
The nucleotide sequence of the inserts revealed an open reading
frame (ORF) of 825 bp, with 100% homology with blaOXA-40.
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Discussion
A. baumannii is an emergent nosocomial pathogen, in part due
to the capability of acquiring resistance to multiple antimicrobial
agents. Clonal outbreaks due to imipenem-resistant strains of
A. baumannii have been reported in particular hospitals.3,5,6
Since 1998, a high imipenem resistance incidence has been
observed among nosocomial A. baumannii isolates in Portugal.
Therefore, it was our purpose to ascertain if the resistance was
due to the dissemination of an imipenem resistance determinant
and/or to the spread of one A. baumannii clone.
Microbiological and spectrophotometric assays showed that
imipenem was hydrolysed by enzymic extracts. An alteration of
carbapenemase activity was not observed in the presence of zinc
and EDTA, suggesting the production of a non-metallo-b-
lactamase. OXA Class D carbapenemases have been identified
mainly in A. baumannii strains collected in Europe.1 – 4 OXA-24,
OXA-25 and OXA-40 b-lactamases have been found in iso-
lates from Spain associated with outbreaks. He´re´tier et al.10
have recently characterized biochemically and genetically the
OXA-40 carbapenemase in a single A. baumannii isolate, recov-
ered from a Portuguese patient who was transferred directly to
France. This study shows that A. baumannii isolates collected
from the three main Portuguese university hospitals between
1998 and 2003 and the 988FFP strain, isolated in 1995, carried
the blaOXA-40 gene, just as the Spanish isolate SM28.
4 Among
the isolates tested, three isolates did not significantly hydrolyse
imipenem, although they carried the blaOXA-40 gene, as shown
by PCR, and in 141FFC strain, confirmed by cloning and
sequencing results. The data indicate that detection of blaOXA-40
by PCR does not always correlate with carbapenemase pro-
duction and may over-report the frequency of OXA carbapene-
mase producers. Other resistance mechanisms, like reduced
permeability of the outer membrane and alteration in PBPs, may
also contribute to carbapenem resistance.5
The clonal relatedness of A. baumannii Portuguese isolates
and SM28 strain was evaluated by antibiotyping and PFGE. All
the isolates presented an identical antibiotic resistance profile,
only variable for aminoglycosides, and a very similar ApaI pat-
tern (Figure 1), differing by no more than three fragments. Such
a correspondence of phenotypic and genotypic characteristics
can be explained by a common clonal origin. They are likely to
represent genotypic variants of the same clone, which, over
time, suffered minor rearrangements. Curiously, the Spanish
strain SM28 exhibited an identical DNA profile to that of the
Portuguese isolates. This observation suggests that the OXA-
40-producing strain might be dispersed in hospitals throughout
the Iberian Peninsula. Moreover, the results reveal that the
spread of this clone dates to at least 1995.
Geographical spread, at a national or international scale, may
be an important feature in the epidemiology of A. baumannii.
Increased resistance among A. baumannii isolates has been gen-
erally observed in the last decades. However, because epidemio-
logical relatedness of strains was not assessed in most of these
studies, susceptibility data may have been influenced by the
unrecognized inclusion of epidemic strains that are often multi-
drug resistant. Our results indicate that the observed carbapenem
resistance among Portuguese A. baumannii isolates is due to the
emergence of a resistant strain under antimicrobial selective
pressure and the spread of an OXA-40-producing epidemic
clone. This observation emphasizes the importance of having
effective infection control measures in our hospitals, such as
early detection of colonized patients, isolation procedures and a
judicious use of antibiotics.
In summary, the present work reports for the first time the dis-
semination among Portuguese hospitals of an A. baumannii strain
carrying blaOXA-40, a clone endemic for several years in this
country, and genetically related to the SM28 strain from Spain.
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Figure 1. PFGE of genomic DNA from representative A. baumannii isolates,
recovered from different Portuguese university hospitals, after digestion with
ApaI (inverse image). (a) and (b) are from different gels. (a) Lane 1, ATCC
19606 strain; lane 2, imipenem-susceptible isolate; lanes 3–5 and 7–9, iso-
lates from HUC (Coimbra), including 141FFc and 150FFC (lanes 3 and 5,
respectively); lane 6, isolate from HSA (Porto); lane 10, isolate from HSM
(Lisboa); lane M, lambda DNA concatemers. (b) lanes 1 and 2, isolates from
HSM; lane 3, isolate SM28.
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